Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension.

Autores de INCLIVA
Participantes ajenos a INCLIVA
- Perez-Hernandez, Javier
- Riffo-Campos, Angela L
- Perez-Gil, Daniel
- Olivares, Dolores
Grupos y Plataformas de I+D+i
Abstract
Urinary albumin excretion (UAE) is a marker of cardiovascular risk and renal damage in hypertension. MicroRNAs (miRNAs) packaged into exosomes function as paracrine effectors in cell communication and the kidney is not exempt. This study aimed to state an exosomal miRNA profile/signature associated to hypertension with increased UAE and the impact of profibrotic TGF-ß1 (transforming growth factor ß1) on exosomes miRNA release. Therefore, exosomes samples from patients with hypertension with/without UAE were isolated and characterized. Three individual and unique small RNA libraries from each subject were prepared (total plasma, urinary, and plasma-derived exosomes) for next-generation sequencing profiling. Differentially expressed miRNAs were over-represented in Kyoto Encyclopedia of Genes and Genomes pathways, and selected miRNAs were validated by real-time quantitative polymerase chain reaction in a confirmation cohort. Thus, a signature of 29 dysregulated circulating miRNAs was identified in UAE hypertensive subjects, regulating 21 pathways. Moreover, changes in the levels of 4 exosomes-miRNAs were validated in a confirmation cohort and found associated with albuminuria. In particular miR-26a, major regulator of TGF-ß signaling, was found downregulated in both type of exosomes when compared with healthy controls and to hypertension normoalbuminurics (P<0.01). Similarly, decreased miR-26a levels were found in podocyte-derived exosomes after TGF-ß stress. Our results revealed an exosomes miRNA signature associated to albuminuria in hypertension. In particular, exosomes miR-26a seemed to play a key role in the regulation of TGF-ß, a relevant effector in podocyte damage. These findings support the use of exosomes miRNAs as biomarkers of cardiovascular risk progression and therapeutic tools in early kidney damage.
Datos de la publicación
- ISSN/ISSNe:
- 0194-911X, 1524-4563
- Tipo:
- Article
- Páginas:
- 960-971
- PubMed:
- 33486986
HYPERTENSION LIPPINCOTT WILLIAMS & WILKINS
Citas Recibidas en Web of Science: 45
Documentos
Filiaciones
Keywords
- albuminuria; exosomes; high-throughput nucleotide sequencing; microRNA; podocytes
Financiación
Proyectos y Estudios Clínicos
MArkers for Subclinical CArdiovascular Risk Assessment
Investigador Principal: JOSEP REDÓN MAS
278249 . UNIVERSITY OF GLASGOW . 2011
Podocitos y sus componentes como biomarcadores de lesión en hipertensión arterial, diabetes y obesidad
Investigador Principal: JOSEP REDÓN MAS
PI12/02615 . INSTITUTO SALUD CARLOS III . 2013
Estudio experimental in vivo e in vitro y la aplicación clínica del impacto de las proteínas del complejo Rhabphilin-Rab en el desarrollo del daño renal y cardiovascular.
Investigador Principal: JOSEP REDÓN MAS
PI16/01402 . 2017
Perfil de microRNAs exosomales y su valor pronostico a largo plazo en el lupus eritematoso sistemico. Asociacion con marcadores establecidos de daño renal.
Investigador Principal: RAQUEL CORTÉS VERGAZ
PI18/01405 . INSTITUTO SALUD CARLOS III . 2019
CD18/00166 (SARA BORRELL) DRA. ANA ORTEGA (2018/136)
Investigador Principal: ANA MARÍA ORTEGA GUTIÉRREZ
CD18/00166 . INSTITUTO SALUD CARLOS III
EXPERIMENTAL AND CLINICAL IMPLICATIONS OF THE RABPHILIN-Rab PROTEIN COMPLEX IN RENAL DAMAGE OF TYPE 2 DIABETES MELLITUS (RabDIAB).
Investigador Principal: JOSEP REDÓN MAS
PI19/01796 . INSTITUTO SALUD CARLOS III . 2020
Cita
Perez J,Riffo AL,Ortega A,Martinez O,Perez D,Olivares D,Solaz E,Martinez F,Martinez S,Chaves FJ,Redon J,Cortes R. Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension. Hypertension. 2021. 77. (3):p. 960-971. IF:9,897. (1).
Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension. Perez J, Riffo AL, Ortega A, Martinez O, Perez D, Olivares D, Solaz E et al. HYPERTENSION. 2021 marzo 03. 77 (3):960-971. DOI:10.1161/HYPERTENSIONAHA.120.16598. PMID:33486986.